1.Second Primary Cancers Following Colorectal Cancer.
Annals of Coloproctology 2014;30(1):2-2
No abstract available.
Colorectal Neoplasms*
;
Neoplasms, Second Primary*
3.Predilection site and risk factor of second primary cancer: A pan-cancer analysis based on the SEER database.
Shan XIONG ; Hengrui LIANG ; Peng LIANG ; Xiuyu CAI ; Caichen LI ; Ran ZHONG ; Jianfu LI ; Bo CHENG ; Feng ZHU ; Limin OU ; Zisheng CHEN ; Yi ZHAO ; Hongsheng DENG ; Zhuxing CHEN ; Zhichao LIU ; Zhanhong XIE ; Feng LI ; Jianxing HE ; Wenhua LIANG
Chinese Medical Journal 2023;136(12):1500-1502
4.Second Primary Cancer Screening: Role of the Primary Care Physician.
Korean Journal of Family Medicine 2017;38(3):109-110
No abstract available.
Humans
;
Mass Screening*
;
Neoplasms, Second Primary*
;
Physicians, Primary Care*
;
Primary Health Care*
6.Metachronous malignant tumors in ipsilateral salivary glands
Hyo Jeong KWON ; Seong Ae KIM ; Jong Won RHIE ; Suk Ho MOON
Archives of Craniofacial Surgery 2019;20(6):412-415
Salivary gland tumors usually appear in solitary mass in single salivary gland. The coexistence of tumors with different histological types occurring within a unilateral parotid gland is an extremely rare event. We experienced a case which two different types of malignant tumors developed at different time points in same gland; metachronous tumors. The second tumor was excised widely and reconstruction was performed by free tissue transfer. Sensory and motor nerve to the left cheek appeared to be intact, and circulation was adequate. This rare case was presented in this article.
Adenocarcinoma
;
Cheek
;
Neoplasms, Second Primary
;
Parotid Gland
;
Salivary Glands
8.Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only.
Su Jin SHIN ; Hosub PARK ; You Na SUNG ; Changhoon YOO ; Dae Wook HWANG ; Jin hong PARK ; Kyu pyo KIM ; Sang Soo LEE ; Baek Yeol RYOO ; Dong Wan SEO ; Song Cheol KIM ; Seung Mo HONG
Cancer Research and Treatment 2018;50(4):1175-1185
PURPOSE: Pancreatic cancer associated double primary tumors are rare and their clinicopathologic characteristics are not well elucidated. MATERIALS AND METHODS: Clinicopathologic factors of 1,352 primary pancreatic cancers with or without associated double primary tumors were evaluated. RESULTS: Of resected primary pancreatic cancers, 113 (8.4%) had associated double primary tumors, including 26 stomach, 25 colorectal, 18 lung, and 13 thyroid cancers. The median interval between the diagnoses of pancreatic cancer and associated double primary tumors was 0.5 months. Overall survival (OS) of pancreatic cancer patients with associated double primary tumors was longer than those with pancreatic cancer only (median, 23.1 months vs. 17.0 months; p=0.002). Patients whose pancreatic cancers were resected before the diagnosis of metachronous tumors had a better OS than patients whose pancreatic cancer resected after the diagnosis of metachronous tumors (48.9 months and 13.5 months, p=0.001) or those whose pancreatic cancers were resected synchronously with non-pancreas tumors (19.1 months, p=0.043). The OS of pancreatic cancer patients with stomach (33.9 months, p=0.032) and thyroid (117.8 months, p=0.049) cancers was significantly better than those with pancreas cancer only (17.0 months). CONCLUSION: About 8% of resected pancreatic cancers had associated double primary tumors, and those from the colorectum, stomach, lung, and thyroid were common. Patients whose pancreatic cancer was resected before the diagnosis of metachronous tumors had better OS than those resected after the diagnosis of metachronous tumors or those resected synchronously.
Diagnosis
;
Humans
;
Lung
;
Neoplasms, Multiple Primary
;
Neoplasms, Second Primary
;
Pancreas
;
Pancreatic Neoplasms*
;
Prognosis*
;
Stomach
;
Thyroid Gland
;
Thyroid Neoplasms
9.Neural Axis Metastasis from Metachronous Pulmonary Basaloid Carcinoma Developed after Chemotherapy & Radiation Therapy of Uterine Cervical Carcinoma.
Myeong Jin OH ; Je Hoon JEONG ; Soo Bin IM ; Jeong Ja KWAK ; Kye Hyun NAM
Korean Journal of Neurotrauma 2016;12(2):167-170
Multiple primary or secondary malignancies after anticancer therapy were recently reported to be increasing in frequency. The authors describe a case of metachronous metastatic pulmonary basaloid carcinoma to the central nervous system that was discovered after chemotherapy and radiation therapy for cervical uterine carcinoma. Two different types of cancer developed within some interval. There's the possibility that a secondary pulmonary neoplasm developed after the chemotherapy and radiotherapy conducted as cervical cancer treatment.
Central Nervous System
;
Drug Therapy*
;
Lung Neoplasms
;
Neoplasm Metastasis*
;
Neoplasms, Second Primary
;
Radiotherapy
;
Uterine Cervical Neoplasms